Clinical trial
Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled…
NCT00353873 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00353873 |
|---|---|
| Title | Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids |
| Official title | A Multicentre, Randomised, Double-blind, Double Dummy, Parallel Group Study to Compare the Salmeterol/Fluticasone Propionate Combination (SeretideTM) at a Dose of 50/100µg Twice Daily and Fluticasone Propionate (FlixotideTM) at a Dose of 200µg Twice Daily, Both Delivered Via a Dry Powder Inhaler… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Fluticasone propionate, Fluticasone propionate/salmeterol |
| Enrollment | 506 |
| Start date | Nov 18, 2005 |
| Primary completion | Oct 26, 2006 |
| Completion | Oct 26, 2006 |
| First posted | Jul 19, 2006 |
| Last update posted | May 29, 2018 |
| Countries | Belgium, Denmark, France, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Russia, Spain, Sweden |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: